Simplex Trading, LLC Adial Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$0.24 - $0.56 $649 - $1,515	2,706 Added 6442.86%	2,748 $0
Q4 2022 Feb 02, 2023	SELL	$0.2 - $9.25 $1,719 - $79,540	-8,599 Reduced 99.51%	42 $0
Q3 2022 Nov 04, 2022	BUY	$0.03 - $46.0 $27 - $42,228	918 Added 11.89%	8,641 $3,000
Q2 2022 Aug 03, 2022	BUY	$28.0 - $53.25 $216,244 - $411,249	7,723 New	7,723 $10,000

5.5K

Ticker ADIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,854,000
Market Cap $26M
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.